Literature DB >> 1714965

Serum amylase levels in homozygous sickle cell patients.

A D Adekile1, O Akinseye-Akintujoye.   

Abstract

Serum amylase was evaluated in a group of 26 steady-state homozygous sickle cell (SS) patients and 11 age-matched HbAA controls. Half (50%) of the SS patients had values above normal while only two of the control group had slightly elevated values. The SS patients had a mean +/- SD value of 301.46 +/- 119.40 iu/L while the control group had 274.36 +/- 89.70 iu/L. The difference between these two values is statistically significant (P less than .05). Males in both groups had significantly higher mean serum amylase values. The values in the SS group did not show an association with age. Higher levels in SS patients suggest a predisposition to chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714965      PMCID: PMC2627077     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Sexual maturation in subjects with sickle cell anemia: studies of serum gonadotropin concentration, height, weight, and skeletal age.

Authors:  N O Olambiwonnu; R Penny; S D Frasier
Journal:  J Pediatr       Date:  1975-09       Impact factor: 4.406

2.  Oral glucose tolerance test in children with sickle cell anaemia.

Authors:  A D Adekile; S O Olusi; D D Oyebola
Journal:  East Afr Med J       Date:  1985-03

3.  Experience with cholelithiasis in patients with sickle cell disease in Nigeria.

Authors:  A D Adekile
Journal:  Am J Pediatr Hematol Oncol       Date:  1985

4.  Cholelithiasis in children with sickle cell disease.

Authors:  G Karayalcin; N Hassani; M Abrams; P Lanzkowsky
Journal:  Am J Dis Child       Date:  1979-03

5.  Studies in sickle cell anemia. XXVII. Complications in infants and children in the United States.

Authors:  R B Scott; A D Ferguson
Journal:  Clin Pediatr (Phila)       Date:  1966-07       Impact factor: 1.168

6.  Plasma cortisol in sickle cell disease.

Authors:  B O Osifo; F A Lukanmbi; A Adekile
Journal:  Acta Haematol       Date:  1988       Impact factor: 2.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.